{
    "clinical_study": {
        "@rank": "30341", 
        "brief_summary": {
            "textblock": "RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing\n      so they stop growing or die. Combining more than one drug may kill more tumor cells.\n\n      PURPOSE: Phase II trial to study the effectiveness of combining cisplatin, paclitaxel, and\n      gemcitabine in treating patients who have progressive unresectable regional or metastatic\n      bladder cancer."
        }, 
        "brief_title": "Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder Cancer", 
        "condition": "Bladder Cancer", 
        "condition_browse": {
            "mesh_term": "Urinary Bladder Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES:\n\n        -  Determine the efficacy and toxicity of cisplatin, paclitaxel, and gemcitabine in\n           patients with progressive unresectable regional or metastatic transitional cell\n           carcinoma of the bladder.\n\n        -  Determine the progression free survival of these patients treated with this regimen.\n\n      OUTLINE: This is a multicenter study.\n\n      Patients receive gemcitabine IV over 30 minutes on days 1 and 8, and cisplatin IV over 1\n      hour and paclitaxel IV over 3 hours on day 1. Treatment repeats every 3 weeks for 6 courses.\n\n      Patients are followed every 3 months until disease progression.\n\n      PROJECTED ACCRUAL: A total of 39 patients will be accrued for this study within 18 months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Histologically proven progressive unresectable regional or metastatic transitional\n             cell carcinoma of the bladder\n\n          -  Measurable disease by CT or MRI scan\n\n               -  Greater than 10 mm\n\n        PATIENT CHARACTERISTICS:\n\n        Age:\n\n          -  18 to 75\n\n        Performance status:\n\n          -  WHO 0-2\n\n        Life expectancy:\n\n          -  At least 3 months\n\n        Hematopoietic:\n\n          -  Absolute neutrophil count at least 1,500/mm^3\n\n          -  Platelet count at least 150,000/mm^3\n\n        Hepatic:\n\n          -  Not specified\n\n        Renal:\n\n          -  Creatinine less than 1.36 mg/dL\n\n        Cardiovascular:\n\n          -  No uncontrolled cardiac disease\n\n          -  No severe cardiac arrhythmias\n\n        Other:\n\n          -  Not pregnant or nursing\n\n          -  No other prior malignancy except curatively treated basal cell or squamous cell skin\n             cancer or carcinoma in situ of the cervix\n\n        PRIOR CONCURRENT THERAPY:\n\n        Biologic therapy:\n\n          -  Prior intravesical immunotherapy for superficial disease allowed\n\n          -  No prior systemic biologic response modifier therapy for advanced disease\n\n        Chemotherapy:\n\n          -  Prior intravesical chemotherapy for superficial disease allowed\n\n          -  No prior systemic chemotherapy for advanced disease\n\n        Endocrine therapy:\n\n          -  Not specified\n\n        Radiotherapy:\n\n          -  Prior radiotherapy allowed\n\n        Surgery:\n\n          -  No prior surgery"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "August 3, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00006118", 
            "org_study_id": "CDR0000068131", 
            "secondary_id": [
                "FRE-GERCOR-U99-1", 
                "EU-20030"
            ]
        }, 
        "intervention": [
            {
                "intervention_name": "cisplatin", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "gemcitabine hydrochloride", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "paclitaxel", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Gemcitabine", 
                "Cisplatin", 
                "Paclitaxel"
            ]
        }, 
        "keyword": [
            "stage III bladder cancer", 
            "stage IV bladder cancer", 
            "transitional cell carcinoma of the bladder"
        ], 
        "lastchanged_date": "July 23, 2008", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/FRE-GERCOR-U99-1"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Dijon", 
                        "country": "France", 
                        "zip": "21000"
                    }, 
                    "name": "Hopital Drevon"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Grenoble", 
                        "country": "France", 
                        "zip": "38043"
                    }, 
                    "name": "CHR de Grenoble - La Tronche"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Levallois-Perret", 
                        "country": "France", 
                        "zip": "92300"
                    }, 
                    "name": "Hopital Perpetuel Secours"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marseille", 
                        "country": "France", 
                        "zip": "13385"
                    }, 
                    "name": "CHU de la Timone"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Metz", 
                        "country": "France", 
                        "zip": "57038"
                    }, 
                    "name": "Hopital Notre-Dame de Bon Secours"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75007"
                    }, 
                    "name": "Hopital Laennec"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75571"
                    }, 
                    "name": "Hopital Saint Antoine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75970"
                    }, 
                    "name": "Hopital Tenon"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Reims", 
                        "country": "France", 
                        "zip": "F-51100"
                    }, 
                    "name": "Polyclinique De Courlancy"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Senlis", 
                        "country": "France", 
                        "zip": "60309"
                    }, 
                    "name": "C.H. Senlis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Thionville", 
                        "country": "France", 
                        "zip": "57126"
                    }, 
                    "name": "Centre Hospitalier Regional Metz Thionville"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Monte Carlo", 
                        "country": "Monaco", 
                        "zip": "98000"
                    }, 
                    "name": "Centre Hospitalier Princesse Grace"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "France", 
                "Monaco"
            ]
        }, 
        "official_title": "First Line Treatment of Locally Advanced or Metastatic Urothelial Carcinoma of the Bladder With a Combination of Cisplatin-Paclitaxel-Gemcitabine", 
        "overall_official": {
            "affiliation": "Hopital Tenon", 
            "last_name": "Catherine Maulard-Durdux, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00006118"
        }, 
        "source": "National Cancer Institute (NCI)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 1999", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2001"
    }, 
    "geocoordinates": {
        "C.H. Senlis": "49.205 2.583", 
        "CHR de Grenoble - La Tronche": "45.189 5.725", 
        "CHU de la Timone": "43.296 5.37", 
        "Centre Hospitalier Princesse Grace": "43.74 7.427", 
        "Centre Hospitalier Regional Metz Thionville": "49.358 6.168", 
        "Hopital Drevon": "47.322 5.041", 
        "Hopital Laennec": "48.857 2.352", 
        "Hopital Notre-Dame de Bon Secours": "49.12 6.177", 
        "Hopital Perpetuel Secours": "48.893 2.288", 
        "Hopital Saint Antoine": "48.857 2.352", 
        "Hopital Tenon": "48.857 2.352", 
        "Polyclinique De Courlancy": "49.258 4.032"
    }
}